Ojeda B, Llanos M, Brunet J, Lacasta A, Alonso M C, Rueda A, Delgado E, Badía J, López López J J
Servicio de Oncología, Hospital de la Santa Creu i Sant Pau, Barcelona.
Med Clin (Barc). 1995 Feb 11;104(5):165-9.
Advanced ovarian neoplasm has bad prognosis. There is little knowledge as to the effect of surgical and chemotherapy treatments on long-term survival.
Seventy-two patients with advanced epithelial ovary carcinoma (53 stage III and 19 stage IV) were treated according to a treatment regimen with reduction surgery, five cycles of chemotherapy with cyclophosphamide, adriamycin and cisplatin (CAP) followed by second revision laparotomy.
The rate of response for the CAP schedule was 80%, of which 16 patients (23%) showed complete response (CR), 7 (10%) partial microscopic response (PMiR) and 33 (47%) partial macroscopic response (PMR). Complete resection of residual masses was performed on the second laparotomy in 14 of the 33 patients with parital response. The median survival for all the group was 36 months with overall actuarial survival of 27% at 10 years. The survival of the group of patients with CR was significantly longer than that of PMiR and other groups. Significant differences favorable for the group of partial response with second attempt radical surgery were found versus the group in which te second surgical resection was not radical. FIGO III stage and prechemotherapy tumor size less than 5 cm were found to have favorable effect in the rate of response and survival.
The use of CAP chemotherapy achieved complete response in 23% of the patients studied. This group of patients showed to have a greater probability of longer survival. Second attempt surgery on the second laparotomy offers therapeutic benefits when radical.
晚期卵巢肿瘤预后较差。关于手术和化疗对长期生存的影响,人们了解甚少。
72例晚期上皮性卵巢癌患者(53例为Ⅲ期,19例为Ⅳ期)按照如下治疗方案进行治疗:先行肿瘤细胞减灭术,然后采用环磷酰胺、阿霉素和顺铂(CAP)进行5个周期的化疗,之后进行第二次剖腹探查术。
CAP化疗方案的有效率为80%,其中16例患者(23%)显示完全缓解(CR),7例(10%)为部分镜下缓解(PMiR),33例(47%)为部分肉眼缓解(PMR)。33例部分缓解的患者中有14例在第二次剖腹探查术中对残留肿块进行了完全切除。所有患者的中位生存期为36个月,10年总精算生存率为27%。CR组患者的生存期明显长于PMiR组和其他组。与第二次手术切除不彻底的组相比,第二次尝试根治性手术的部分缓解组患者的生存情况有显著差异。发现国际妇产科联盟(FIGO)Ⅲ期以及化疗前肿瘤大小小于5 cm对缓解率和生存率有有利影响。
在所研究的患者中,使用CAP化疗使23%的患者达到完全缓解。这组患者显示出更长生存期的可能性更大。第二次剖腹探查术中进行第二次尝试手术,若为根治性手术则具有治疗益处。